1Ku Sy,Suh CS,Kim SH,et al. A pilot study of the use low dose hu-man menopausal gonadotropin in ovulation induction[ J]. Eur J Ob- stet Gynecol Reprod Biol, 2003,109 ( 1 ) :55 - 9.
3Butletti C, DeZiegler D, Stefanett M, et al. Endometriosis: absence of recurrence in patients after endometrial ablation[J]. Hum Reprod, 2001,16(12) :2676-2679.
4Osuga Y. Novel therapeutic strategies for endometriosis: a pathophysiological perspective[J]. Gynecol Obstet Invest, 2008,66 [Suppl 1]:3-9.
5Hirota Y, Osuga Y, Koga K, et al. Possible implication of midkine in the development of endometriosis [J]. Hum Reprod, 2005,20(4) :1084-1089.
6Harada M, Osuga Y, Hirota Y, et al. Mechanical stretch stimulates interleukin 8 production in endometrial stromal cells: possible implications in endometrium-related events [J].J Clin Endocrinol Metah, 2005,90(2)..1144-1148.
7Tesone M, Bilotas M, Baranao RI, et al. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis [J]. Gynecol Obstet Invest, 2008,66 [Suppl 1]:10-18.
8Bilotas M, Baranao RI, Buquet R, et al. Effect of GnRH analogues on apoptosis and expression of Bcl-2, Bax, Fas and FasL proteins in endometrial epithelial cell cultures from patients with endometriosis and controls [J].Hum Reprod, 2006,22 (2) : 644-653.
9Borroni R, DiBlasio AM, Gaffuri B, et al. Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate [J].Mol Cell Endocrinol, 2000,159 (1-2): 37-43.
10Kupker W, Felberbaum RE, Krapp M, et al. Use of GnRH antagonists in treatment of endometriosis [J].Reprod Biomed Online,2002,5(1):12-16.
2Missmer SA, Hankinson SE, Spiegelman D, et al. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors[J]. Am J Epidemiol, 2004, 160:784-796.
3Ozkan S, Murk W, Arici A. Endometriosis and infertility: Epidemiology and evidence-based treatments[J]. Ann N Y Acad Sci, 2008,1127: 92-100.
4Ma C, Qiao J, Liu P, et al. Ovarian suppression treatment prior to in-vitro fertilization and embryo transfer in Chinese women with stage or endometriosis[J]. Int J Gynaecol Obstet, 2008,100-167.
5Surrey ES, Sitverberg KM, Surrey MW, et al. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis[J]. Fertil Steril, 2002, 78(4): 699-704.
6Ricks D, Nickel I, Kropf S, etal. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin releasing hormone analogs in patients with endometriosis[J]. Fertil Steril, 2002, 78(4) :757-762.
8Opφien HK, Fedorcsak P, Byholm TA, et al. Complete surgical removal of minimal and mild endometriosis improves outcome of subsequent IVF/ICSI treatment [J]. Reprod BioMed Online, 2011,23(3) :389-395.
9Kuivasaari P, Hippelainen M, Anttila M, et al. Effect of endometriosis on IVF/ICSI outcome: Stage Ⅲ/Ⅳ endometriosis worsens cumulative pregnancy and live-born rates [J]. Human Reproduct, 2005,20(11):3130-3135.
10Sallam HN, Gareia-Velasco JA, Dias S, etal. Long-termpituitary down-regulation before in vitro fertilization(IVF) for women with endometriosis [ J ]. Cochrane databaseof systematic reviews (Online), 2006,1 (CD004635).
